HEADER TRANSPORT PROTEIN 17-APR-14 4PD7 TITLE STRUCTURE OF VCCNT BOUND TO ZEBULARINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUPC FAMILY PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: VIBRIO CHOLERAE SEROTYPE O1; SOURCE 3 ORGANISM_TAXID: 243277; SOURCE 4 STRAIN: ATCC 39315 / EL TOR INABA N16961; SOURCE 5 GENE: VC_2352; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: C41 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET26 KEYWDS MEMBRANE PROTEIN, DRUG TRANSPORTER, SODIUM-COUPLED TRANSPORTER, KEYWDS 2 ZEBULARINE, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Z.L.JOHNSON,S.-Y.LEE REVDAT 5 27-SEP-23 4PD7 1 REMARK REVDAT 4 25-DEC-19 4PD7 1 REMARK REVDAT 3 20-SEP-17 4PD7 1 COMPND SOURCE REMARK REVDAT 2 01-OCT-14 4PD7 1 JRNL REVDAT 1 13-AUG-14 4PD7 0 JRNL AUTH Z.L.JOHNSON,J.H.LEE,K.LEE,M.LEE,D.Y.KWON,J.HONG,S.Y.LEE JRNL TITL STRUCTURAL BASIS OF NUCLEOSIDE AND NUCLEOSIDE DRUG JRNL TITL 2 SELECTIVITY BY CONCENTRATIVE NUCLEOSIDE TRANSPORTERS. JRNL REF ELIFE V. 3 03604 2014 JRNL REFN ESSN 2050-084X JRNL PMID 25082345 JRNL DOI 10.7554/ELIFE.03604 REMARK 2 REMARK 2 RESOLUTION. 2.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.22 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.390 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 14932 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 756 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.2209 - 4.9713 1.00 2877 157 0.2171 0.2558 REMARK 3 2 4.9713 - 3.9471 1.00 2848 151 0.1997 0.2505 REMARK 3 3 3.9471 - 3.4485 1.00 2820 149 0.1938 0.2072 REMARK 3 4 3.4485 - 3.1333 1.00 2833 153 0.2175 0.2495 REMARK 3 5 3.1333 - 2.9088 1.00 2798 146 0.2519 0.2787 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.69 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2976 REMARK 3 ANGLE : 0.676 4039 REMARK 3 CHIRALITY : 0.021 490 REMARK 3 PLANARITY : 0.003 500 REMARK 3 DIHEDRAL : 11.040 1006 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4PD7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-APR-14. REMARK 100 THE DEPOSITION ID IS D_1000201077. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14952 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.14100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.76600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3TIJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 37-42% PEG 400, 100 MM CACL2, PH 9.5, REMARK 280 LIQUID DIFFUSION, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 41.32900 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 41.32900 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 41.32900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS ASYM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 43630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -146.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 59.90550 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 -103.75937 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 119.81100 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -5 REMARK 465 PRO A -4 REMARK 465 ALA A -3 REMARK 465 VAL A -2 REMARK 465 PRO A -1 REMARK 465 ARG A 0 REMARK 465 MET A 1 REMARK 465 ASN A 230 REMARK 465 GLU A 231 REMARK 465 ASP A 232 REMARK 465 ILE A 233 REMARK 465 THR A 234 REMARK 465 LEU A 235 REMARK 465 ASP A 236 REMARK 465 GLY A 237 REMARK 465 GLY A 238 REMARK 465 ASP A 239 REMARK 465 ASP A 240 REMARK 465 SER A 417 REMARK 465 PHE A 418 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TRP A 51 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 51 CZ3 CH2 REMARK 470 LYS A 85 CG CD CE NZ REMARK 470 GLU A 88 CG CD OE1 OE2 REMARK 470 GLN A 122 CG CD OE1 NE2 REMARK 470 TRP A 123 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 123 CZ3 CH2 REMARK 470 ARG A 126 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 127 CG1 CG2 CD1 REMARK 470 PHE A 164 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 167 CG CD CE NZ REMARK 470 LYS A 226 CD CE NZ REMARK 470 GLN A 228 CG CD OE1 NE2 REMARK 470 ASP A 229 CG OD1 OD2 REMARK 470 ILE A 284 CG1 CG2 CD1 REMARK 470 PHE A 288 CG CD1 CD2 CE1 CE2 CZ REMARK 470 TRP A 301 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 301 CZ3 CH2 REMARK 470 TRP A 314 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 314 CZ3 CH2 REMARK 470 ASN A 315 CG OD1 ND2 REMARK 470 GLU A 345 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 23 99.54 -161.54 REMARK 500 VAL A 161 32.62 -140.18 REMARK 500 ILE A 184 -143.96 -117.93 REMARK 500 ALA A 330 -94.07 -131.41 REMARK 500 ALA A 367 93.17 -67.93 REMARK 500 ALA A 383 78.61 -153.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 502 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 149 O REMARK 620 2 ASN A 149 OD1 103.0 REMARK 620 3 VAL A 152 O 83.0 94.5 REMARK 620 4 SER A 183 OG 78.0 87.8 160.9 REMARK 620 5 ILE A 184 O 94.1 159.3 75.8 107.4 REMARK 620 6 HOH A 603 O 162.9 92.7 102.8 96.0 72.2 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZE8 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMU A 503 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3TIJ RELATED DB: PDB REMARK 900 3TIJ CONTAINS THE SAME PROTEIN BOUND TO URIDINE REMARK 900 RELATED ID: 4PB1 RELATED DB: PDB REMARK 900 RELATED ID: 4PD5 RELATED DB: PDB REMARK 900 RELATED ID: 4PB2 RELATED DB: PDB REMARK 900 RELATED ID: 4PD8 RELATED DB: PDB REMARK 900 RELATED ID: 4PD9 RELATED DB: PDB REMARK 900 RELATED ID: 4PDA RELATED DB: PDB DBREF 4PD7 A 1 418 UNP Q9KPL5 Q9KPL5_VIBCH 1 418 SEQADV 4PD7 GLY A -5 UNP Q9KPL5 EXPRESSION TAG SEQADV 4PD7 PRO A -4 UNP Q9KPL5 EXPRESSION TAG SEQADV 4PD7 ALA A -3 UNP Q9KPL5 EXPRESSION TAG SEQADV 4PD7 VAL A -2 UNP Q9KPL5 EXPRESSION TAG SEQADV 4PD7 PRO A -1 UNP Q9KPL5 EXPRESSION TAG SEQADV 4PD7 ARG A 0 UNP Q9KPL5 EXPRESSION TAG SEQRES 1 A 424 GLY PRO ALA VAL PRO ARG MET SER LEU PHE MET SER LEU SEQRES 2 A 424 ILE GLY MET ALA VAL LEU LEU GLY ILE ALA VAL LEU LEU SEQRES 3 A 424 SER SER ASN ARG LYS ALA ILE ASN LEU ARG THR VAL GLY SEQRES 4 A 424 GLY ALA PHE ALA ILE GLN PHE SER LEU GLY ALA PHE ILE SEQRES 5 A 424 LEU TYR VAL PRO TRP GLY GLN GLU LEU LEU ARG GLY PHE SEQRES 6 A 424 SER ASP ALA VAL SER ASN VAL ILE ASN TYR GLY ASN ASP SEQRES 7 A 424 GLY THR SER PHE LEU PHE GLY GLY LEU VAL SER GLY LYS SEQRES 8 A 424 MET PHE GLU VAL PHE GLY GLY GLY GLY PHE ILE PHE ALA SEQRES 9 A 424 PHE ARG VAL LEU PRO THR LEU ILE PHE PHE SER ALA LEU SEQRES 10 A 424 ILE SER VAL LEU TYR TYR LEU GLY VAL MET GLN TRP VAL SEQRES 11 A 424 ILE ARG ILE LEU GLY GLY GLY LEU GLN LYS ALA LEU GLY SEQRES 12 A 424 THR SER ARG ALA GLU SER MET SER ALA ALA ALA ASN ILE SEQRES 13 A 424 PHE VAL GLY GLN THR GLU ALA PRO LEU VAL VAL ARG PRO SEQRES 14 A 424 PHE VAL PRO LYS MET THR GLN SER GLU LEU PHE ALA VAL SEQRES 15 A 424 MET CYS GLY GLY LEU ALA SER ILE ALA GLY GLY VAL LEU SEQRES 16 A 424 ALA GLY TYR ALA SER MET GLY VAL LYS ILE GLU TYR LEU SEQRES 17 A 424 VAL ALA ALA SER PHE MET ALA ALA PRO GLY GLY LEU LEU SEQRES 18 A 424 PHE ALA LYS LEU MET MET PRO GLU THR GLU LYS PRO GLN SEQRES 19 A 424 ASP ASN GLU ASP ILE THR LEU ASP GLY GLY ASP ASP LYS SEQRES 20 A 424 PRO ALA ASN VAL ILE ASP ALA ALA ALA GLY GLY ALA SER SEQRES 21 A 424 ALA GLY LEU GLN LEU ALA LEU ASN VAL GLY ALA MET LEU SEQRES 22 A 424 ILE ALA PHE ILE GLY LEU ILE ALA LEU ILE ASN GLY MET SEQRES 23 A 424 LEU GLY GLY ILE GLY GLY TRP PHE GLY MET PRO GLU LEU SEQRES 24 A 424 LYS LEU GLU MET LEU LEU GLY TRP LEU PHE ALA PRO LEU SEQRES 25 A 424 ALA PHE LEU ILE GLY VAL PRO TRP ASN GLU ALA THR VAL SEQRES 26 A 424 ALA GLY GLU PHE ILE GLY LEU LYS THR VAL ALA ASN GLU SEQRES 27 A 424 PHE VAL ALA TYR SER GLN PHE ALA PRO TYR LEU THR GLU SEQRES 28 A 424 ALA ALA PRO VAL VAL LEU SER GLU LYS THR LYS ALA ILE SEQRES 29 A 424 ILE SER PHE ALA LEU CYS GLY PHE ALA ASN LEU SER SER SEQRES 30 A 424 ILE ALA ILE LEU LEU GLY GLY LEU GLY SER LEU ALA PRO SEQRES 31 A 424 LYS ARG ARG GLY ASP ILE ALA ARG MET GLY VAL LYS ALA SEQRES 32 A 424 VAL ILE ALA GLY THR LEU SER ASN LEU MET ALA ALA THR SEQRES 33 A 424 ILE ALA GLY PHE PHE LEU SER PHE HET ZE8 A 501 16 HET NA A 502 1 HET DMU A 503 33 HETNAM ZE8 ZEBULARINE HETNAM NA SODIUM ION HETNAM DMU DECYL-BETA-D-MALTOPYRANOSIDE HETSYN DMU DECYLMALTOSIDE FORMUL 2 ZE8 C9 H12 N2 O5 FORMUL 3 NA NA 1+ FORMUL 4 DMU C22 H42 O11 FORMUL 5 HOH *3(H2 O) HELIX 1 AA1 LEU A 3 LEU A 20 1 18 HELIX 2 AA2 ASN A 23 ILE A 27 5 5 HELIX 3 AA3 ASN A 28 TYR A 48 1 21 HELIX 4 AA4 VAL A 49 GLY A 79 1 31 HELIX 5 AA5 GLY A 80 SER A 83 5 4 HELIX 6 AA6 GLY A 84 GLY A 91 1 8 HELIX 7 AA7 GLY A 92 PHE A 95 5 4 HELIX 8 AA8 ILE A 96 VAL A 101 1 6 HELIX 9 AA9 VAL A 101 LEU A 118 1 18 HELIX 10 AB1 GLY A 119 GLY A 137 1 19 HELIX 11 AB2 SER A 139 ASN A 149 1 11 HELIX 12 AB3 GLU A 156 VAL A 165 5 10 HELIX 13 AB4 THR A 169 SER A 183 1 15 HELIX 14 AB5 ALA A 185 SER A 194 1 10 HELIX 15 AB6 LYS A 198 MET A 221 1 24 HELIX 16 AB7 ASN A 244 TRP A 287 1 44 HELIX 17 AB8 LYS A 294 ILE A 310 1 17 HELIX 18 AB9 PRO A 313 ASN A 315 5 3 HELIX 19 AC1 GLU A 316 ALA A 330 1 15 HELIX 20 AC2 ASN A 331 ALA A 340 1 10 HELIX 21 AC3 PRO A 341 THR A 344 5 4 HELIX 22 AC4 SER A 352 CYS A 364 1 13 HELIX 23 AC5 LEU A 369 LEU A 382 1 14 HELIX 24 AC6 ALA A 383 LYS A 385 5 3 HELIX 25 AC7 ARG A 386 PHE A 415 1 30 LINK O ASN A 149 NA NA A 502 1555 1555 2.44 LINK OD1 ASN A 149 NA NA A 502 1555 1555 2.43 LINK O VAL A 152 NA NA A 502 1555 1555 2.41 LINK OG SER A 183 NA NA A 502 1555 1555 2.43 LINK O ILE A 184 NA NA A 502 1555 1555 2.39 LINK NA NA A 502 O HOH A 603 1555 1555 2.35 SITE 1 AC1 11 GLN A 154 TYR A 192 ASN A 331 GLU A 332 SITE 2 AC1 11 PHE A 333 PHE A 366 ASN A 368 SER A 371 SITE 3 AC1 11 ILE A 374 HOH A 601 HOH A 602 SITE 1 AC2 5 ASN A 149 VAL A 152 SER A 183 ILE A 184 SITE 2 AC2 5 HOH A 603 SITE 1 AC3 3 ALA A 243 ASN A 244 ALA A 391 CRYST1 119.811 119.811 82.658 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008346 0.004819 0.000000 0.00000 SCALE2 0.000000 0.009638 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012098 0.00000